-
Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.
-
As hazy air from fires out West wafts across the country, some people are at higher risk of health problems, including children, older people and those with lung conditions. Here's how to stay safe.
-
Drugmaker GSK stopped making asthma inhaler Flovent earlier this year. That’s left patients struggling to find other medication their insurance will cover.Children have been hit especially hard.
-
Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution and allergens.
-
The purchase "is the latest reprehensible choice from a company that has profited from addicting users to its deadly products," the American Lung Association said.
-
Boston Children's Hospital saw a precipitous drop in cases during the spring shutdown, and the trend continues. Researchers are asking why — and what it would take to keep up the change post-pandemic.
-
Young athletes — especially girls — can struggle with a breathing problem that appears to be asthma. The real cause of the problem is in the vocal cords.
-
Among Native Americans, asthma rates are high, and those with asthma end up in clinics more often, miss more school and work, and are more likely to die from the condition, according to the CDC.
-
New cases of asthma dropped dramatically in Los Angeles communities where air quality improved the most over 20 years. The results illustrate health benefits from pollution control.
-
Toxic stress in childhood can lead to a lifetime of health problems and, ultimately, a shorter life. Here's what schools can do to help.